Development of therapeutic agents that target carbonic anhydrase enzymes

这项研究将发现新的化学实体（化合物），可能会导致治疗癌症、青光眼和疟疾的疗法。这项研究支持了一种机制，在与行业合作之前，为我们的化合物增加价值，将这里的发现转化为可交付的疗法，可以造福数百万人的健康，从而为澳大利亚经济提供潜在的高价值贡献。多学科研究人员网络的经验和承诺为未来的科学家在发现和表征新化学物质及其与疾病目标的相互作用方面提供了特殊的培训和就业机会。

This research will discover new chemical entities (compounds) that may lead to therapies for the treatment of cancer, glaucoma and malaria. The research underpins a mechanism to add value to our compounds before partnering with industry to transform the discoveries made here to deliverable therapies that could benefit the health of millions, thus offering a potentially high value contribution to the Australian economy. The experience and commitment of the multi-disciplinary network of researchers offers exceptional training and employment opportunities for tomorrow's scientists in techniques for discovery and characterisation of novel chemicals, and their interaction with disease targets.